Investigation of Glypican-4 and -6 by Infrared Spectral Imaging during the Hair Growth Cycle.
glycosaminoglycans
glypicans
hair follicle growth
infrared imaging
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
21 Feb 2023
21 Feb 2023
Historique:
received:
23
11
2022
revised:
13
01
2023
accepted:
14
02
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
15
3
2023
Statut:
epublish
Résumé
The expression of glypicans in different hair follicle (HF) compartments is still poorly understood. Heparan sulfate proteoglycans (HSPGs) distribution in HF is classically investigated by conventional histology, biochemical analysis, and immunohistochemistry. Our previous study proposed a novel approach to assess hair histology and glypican-1 (GPC1) distribution changes in the HF at different phases of the hair growth cycle using infrared spectral imaging (IRSI). We show in the present manuscript for the first time complementary data on the distribution of glypican-4 (GPC4) and glypican-6 (GPC6) in HF at different phases of the hair growth cycle using IR imaging. Findings were supported by Western blot assays focusing on the GPC4 and GPC6 expression in HFs. Like all proteoglycan features, the glypicans are characterized by a core protein to which sulfated and/or unsulfated glycosaminoglycan (GAG) chains are covalently linked. Our study demonstrates the capacity of IRSI to identify the different HF tissue structures and to highlight protein, proteoglycan (PG), GAG, and sulfated GAG distribution in these structures. The comparison between anagen, catagen, and telogen phases shows the qualitative and/or quantitative evolution of GAGs, as supported by Western blot. Thus, in one analysis, IRSI can simultaneously reveal the location of proteins, PGs, GAGs and sulfated GAGs in HFs in a chemical and label-free manner. From a dermatological point of view, IRSI may constitute a promising technique to study alopecia.
Identifiants
pubmed: 36901723
pii: ijms24054291
doi: 10.3390/ijms24054291
pmc: PMC10002317
pii:
doi:
Substances chimiques
Glypicans
0
Heparan Sulfate Proteoglycans
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Clin Invest. 2006 Jan;116(1):249-60
pubmed: 16395407
Lab Invest. 2009 Aug;89(8):844-56
pubmed: 19506554
J Biol Chem. 1998 Sep 4;273(36):22936-42
pubmed: 9722514
Dev Biol. 2016 Nov 15;419(2):321-335
pubmed: 27640326
Dev Cell. 2010 Apr 20;18(4):605-20
pubmed: 20412775
Bioessays. 2014 May;36(5):513-25
pubmed: 24665045
Am J Dermatopathol. 2002 Dec;24(6):484-9
pubmed: 12454600
Development. 2003 Oct;130(20):4919-29
pubmed: 12930779
Genome Biol. 2008;9(5):224
pubmed: 18505598
J Int Med Res. 2006 Sep-Oct;34(5):514-9
pubmed: 17133780
Dev Dyn. 2000 Nov;219(3):353-67
pubmed: 11066092
J Invest Dermatol. 2001 Jul;117(1):3-15
pubmed: 11442744
Biomolecules. 2021 Jan 30;11(2):
pubmed: 33573119
J Int Med Res. 1991 Mar-Apr;19(2):147-52
pubmed: 1864451
Exp Dermatol. 2018 Jul;27(7):701-720
pubmed: 29672929
Dev Cell. 2004 Oct;7(4):503-12
pubmed: 15469839
Br J Dermatol. 2008 Feb;158(2):234-42
pubmed: 18067481
Exp Dermatol. 2008 Jul;17(7):592-609
pubmed: 18558994
J Biol Chem. 2014 Sep 5;289(36):25211-26
pubmed: 25053416
J Histochem Cytochem. 2020 Dec;68(12):841-862
pubmed: 32623934
Stem Cells. 2012 Sep;30(9):1863-74
pubmed: 22761013
Chem Rev. 2018 Sep 26;118(18):9152-9232
pubmed: 30204432
Dermatol Res Pract. 2020 May 5;2020:8125081
pubmed: 32425997
Exp Gerontol. 2019 Oct 15;126:110693
pubmed: 31430521
J Cell Biol. 2017 Sep 4;216(9):2911-2926
pubmed: 28696225
Nature. 2020 Sep;585(7823):85-90
pubmed: 32699409